Chemoinformaics analysis of 31-Nor-Lanost-8-En-3-Beta-Ol
Molecular Weight | 398.675 | nRot | 4 |
Heavy Atom Molecular Weight | 352.307 | nRig | 21 |
Exact Molecular Weight | 398.355 | nRing | 4 |
Solubility: LogS | -6.738 | nHRing | 0 |
Solubility: LogP | 7.225 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 78.2345 |
nHD | 1 | BPOL | 46.1475 |
QED | 0.481 |
Synth | 4.612 |
Natural Product Likeliness | 3.413 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.75 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.782 |
MDCK | 0.00000891 |
BBB | 0.476 |
PPB | 0.96964 |
VDSS | 4.25 |
FU | 0.0121074 |
CYP1A2-inh | 0.071 |
CYP1A2-sub | 0.463 |
CYP2c19-inh | 0.067 |
CYP2c19-sub | 0.945 |
CYP2c9-inh | 0.112 |
CYP2c9-sub | 0.657 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.857 |
CYP3a4-inh | 0.181 |
CYP3a4-sub | 0.546 |
CL | 20.604 |
T12 | 0.01 |
hERG | 0.056 |
Ames | 0.027 |
ROA | 0.103 |
SkinSen | 0.087 |
Carcinogencity | 0.031 |
EI | 0.009 |
Respiratory | 0.594 |
NR-Aromatase | 0.032 |
Antiviral | No |
Prediction | 0.689794 |